InoteveraGaidhi rinotevera
AI muKutenga uye Kushandisa Kuongorora
Maindasitiri
MABHUKU EINDUSTRIES
Zvishandiso zveAI zvehematology zvinogona kuongorora mifananidzo yedhijitari yemifananidzo yebhuru kuti aone mhando dzezvibereko kana kuratidza mapatani anogona kusvibisa kune nyanzvi yedhijitari.
Teerera kugwaro iriAI-yakarondedzerwa · ~3 min
Zvinokosha nekuti chiratidzo chinogona kutungamira kutarisirwa, asi kuongorora mifananidzo chete hakusi kusimbisa leukemia, malaria kana chirwere chimwe chete.
A peripheral blood smear is a stained slide that lets laboratory professionals examine the shape and appearance of blood cells. Digital morphology systems capture microscope images and may sort cells into categories, flag atypical forms or help prioritize fields for manual review. Research also applies computer vision to malaria parasites in thick or thin smears. These tasks can support workflow, but classifying a cell image is not the same as diagnosing a patient. An abnormal-looking cell may require review with the full blood count, clinical history and additional tests such as flow cytometry or molecular studies. Models are trained on annotated examples, then tested on held-out images or slides. Image quality, stain, scanner, magnification, cell preparation and the mix of healthy and abnormal cases can all affect performance. A model that performs well on one dataset may not transfer to another laboratory. In a prospective validation of the AIDMAN malaria image system, investigators tested 64 patient smears and reported results similar to expert microscopy; that small evaluation does not establish performance across countries, devices or routine settings. Other leukocyte-classification studies likewise evaluate defined cell classes against manual review rather than replace a complete hematology workup. A useful deployment gives a trained technologist or pathologist access to flagged images and the original slide, a way to correct classifications and clear escalation rules. Laboratories should assess false negatives, false positives, patient-level performance and subgroup or site differences. FDA’s device framework distinguishes intended uses and requires an appropriate review pathway for medical software. AI may help organize visual work, but a clinician interprets the smear and integrates it with other evidence.
Sisitimu yemifananidzo yedhijitari inobatanidza vanhu vanokwanisa kuve leukocytes kuitira kuti tekinoroji aongorore zvibereko zvisina kujairika pamifananidzo yepakutanga.
Muenzaniso weongororo ye malaria unoratidza nzvimbo dzinoratidzika separasitiki mumufananidzo webhuru wakapfeka kuti uongororwe ne microscopy.
Laboratory inofananidza mhando dze leukocyte dze algorithm neongororo yevanyanzvi pane slides kubva kumasaiti akasiyana.
Mushandi wezve ropa anotarisa sero rakaratidzwa sero rebhuroka uye anoraira bvunzo dzekusimbisa sezvinoratidzwa nezvekurapa.
Zvishandiso zveDigital smear zvinogona kuwedzera ongororo yemifananidzo, nzvimbo yemasero uye kubatanidza kune mahematology analyzers. Izvi zvinogona kubatsira ma labs kugadzirisa huwandu hwe slide, asi zvinogonawo kuwedzera ongororo inotevera kana ma flags asina kugadziriswa zvakanaka. Tsvakurudzo yemberi inofanira kuyedza mashandiro pakati pemahofisi, ma protocol ekupenda uye kuwanda kwechirwere, uye kuratidza zvikanganiso zvinokosha zvechiremba pamwe chete nekunyatso kuverenga. Kusanganisa kunofanira kuchengetedza kugona kwe pathologist kuongorora mifananidzo isina kuchinjwa uye kudzima label. AI inogona kuita microscopy inowanikwa nyore; haina kutsiva basa rekupfupisa.
Tsamba yemahara
Nhatu dzakasimbiswa dzeAI nyaya mangwanani ega ega pakati pevhiki, dzakanyorwa neChirungu chakajeka. Yemahara zvachose, hapana ads.
Imwe email zuva rega rega revhiki. Bvisa kunyoresa kamwe chete. Hatimbotengese kana kugovera kero yako.
Zviedze iwe pachako
Mhinduro yepakarepo pamhinduro yega yega, uye chitupa chinogovaniswa chine ID inobatika kana wapedza kosi.
Tsigira dzidzo yemahara yeAI. AI Understanding ndeye 501(c)(3) isingabatsiri - hapana ads, hapana paywall, zvachose. Ita chipo
Zvishandiso zveAI muhematology zvinogona kuongorora mifananidzo ye digital yemifananidzo yemvura kuti vaparidze mhando dze masero kana kuratidza mapatani anogona kusanganisira chirwere kune nyanzvi ye lab yakadzidziswa. Zvinokosha nekuti flag inogona kutungamira kutarisa, asi classification yemifananidzo chete haina kusimbisa leukemia, malaria kana chirwere chimwe.
Gwaro rinotsanangura classification uye flagging sechikamu chebatsiro rekutarisa nyanzvi.
Prospective AIDMAN validation yakatarisa mhedzisiro yayo ne microscopy kune 64 vatengi pa hospital imwe.
Maitiro e cell anotsanangurwa pamwe chete nezvimwe zvinyorwa zvechiremba ne lab.
Kutorwa kwemifananidzo uye kugadzirira kunogona kusiyana pakati pemalaboratory.
Gwaro rinotaura kuti dzimwe bvunzo dzinogona kudikanwa kuti dzisimbise chawanikwa chetsinga.
Ramba uchidzidza
Mamwe madhairekitori akasarudzirwa nyaya iyi
InoteveraGaidhi rinotevera
AI muKutenga uye Kushandisa Kuongorora
Maindasitiri